Skip to content

Author

Emad A. Albadawi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

The neuroprotective efficacy of cholecalciferol: Targeting oxidative stress and NF-κB-mediated neuroinflammation in a valproic acid-induced autism model.

BACKGROUND Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental condition characterized by repetitive behaviors, heightened anxiety and altered exploratory motivation, which are closely linked to oxidative stress, neuroinflammation, and glial dysfunction. Although vitamin D₃ (cholecalciferol) exhibits...

M. Eldesoqui, O. Erfan, R. Sherif et al. · 0 citations
Oct 2026

Hesperidin attenuates methotrexate-induced cardiotoxicity: Modulation of Nrf2 antioxidant defense and NF-κB/iNOS proinflammatory signaling.

Results indicate that hesperidin effectively attenuates MTX-induced cardiotoxicity and that HES may hold potential as a supplementary agent to minimize the cardiotoxic complications associated with MTX regimens, warranting further investigation.

M. Eldesoqui, E. Albadawi, O. Erfan et al. · 0 citations
Open access Oct 2026

The neurological, cardiac, and hepatic toxic effects of ivermectin and hydroxychloroquine and the ameliorative role of vitamin C: a biochemical, histological, and immunohistochemical experimental study

Physicians ought to be cautious about the toxic impact of an extensive range of potentially unproven medications when evaluating or managing disease outbreaks. This work aimed to evaluate the potentially toxic effects of ivermectin and hydroxychloroquine, which were used in the pandemic COVID 19; and in other various d...

M. M. Mohamed, Mohammed Abdelhakim Abdelaleem, S. Mokhemer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.